Clinical outcomes of half-dose extended anticoagulation in cancer-associated pulmonary thromboembolism: a real-world cohort study

Back

Delegates Premium Access

Clinical outcomes of half-dose extended anticoagulation in cancer-associated pulmonary thromboembolism: a real-world cohort study

Session: Management of cardiovascular disease in cancer patients and survivors

Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer

Speaker: Doctor M. Bak (Seoul, KR)

Event: ESC Cardio-Oncology 2025

Congress Presentation

Add to my library

About the speaker

Doctor Minjung Bak

Samsung Medical Center, Seoul (Korea (Republic of))

0 follower

4 more presentations in this session

Arterial stiffness in cancer survivors: the prognostic value of estimated pulse wave velocity (ePWV) in U.S cancer population from NHANES 2009-2018

Speaker: Doctor M. Al-Jarshawi (Stoke-on-Trent, GB)

Disparities between cardiologists and oncologists therapeutic strategies in cardio-oncology. A national cross-sectional survey

Speaker: Assistant Professor A. Ivanescu (Bucharest, RO)

Net clinical benefit of 18-month over 6-month rivaroxaban in patients with cancer and acute low-risk pulmonary embolism: Insight from the ONCO PE trial

Speaker: Doctor Y. Nishimoto (Toyonaka, JP)

Endothelial syndrome as a life-threatening complication in haematopoietic stem cell transplantation

Speaker: Doctor V. Cetoretta (Ancona, IT)

Access the full session

Management of cardiovascular disease in cancer patients and survivors

Speakers: Doctor M. Bak, Doctor M. Al-Jarshawi, Assistant Professor A. Ivanescu, Doctor Y. Nishimoto, Doctor V. Cetoretta

Access

About the event

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources